In pancreatic cancer, galectin-9 binds to dectin-1 on macrophages and suppresses immune cell activity by reprogramming CD4+ and CD8+ T cells, promoting the formation of an immunosuppressive microenvironment in PDAC [127]. The gene discussed is LGALS9; the disease is pancreatic neoplasm.